$1.72 Billion is the total value of Sofinnova Investments, Inc.'s 61 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PTGX | Exit | Protagonist Therapeutics Inccall | $0 | – | -100,000 | -100.0% | -0.07% | – |
| CLDX | Exit | Celldex Therapeutics Inc | $0 | – | -48,304 | -100.0% | -0.11% | – |
| JNCE | Exit | Jounce Therapeutics Inc | $0 | – | -981,928 | -100.0% | -0.25% | – |
| Exit | Amylyx Pharmaceuticals Inc | $0 | – | -187,381 | -100.0% | -0.30% | – | |
| XNCR | Exit | Xencor Inc | $0 | – | -158,164 | -100.0% | -0.36% | – |
| SGEN | Exit | Seagen Inc | $0 | – | -27,894 | -100.0% | -0.41% | – |
| ARGX | Exit | argenx SEsponsored adr | $0 | – | -15,000 | -100.0% | -0.47% | – |
| CCXI | Exit | ChemoCentryx Inccall | $0 | – | -250,000 | -100.0% | -0.52% | – |
| HZNP | Exit | Horizon Therapeutics PLC | $0 | – | -100,297 | -100.0% | -0.67% | – |
| CCXI | Exit | ChemoCentryx Inc | $0 | – | -636,659 | -100.0% | -1.31% | – |
| VRTX | Exit | Vertex Pharmaceuticals Inc | $0 | – | -74,758 | -100.0% | -1.75% | – |
| XBI | Exit | SPDR S&P Biotech ETFput | $0 | – | -400,000 | -100.0% | -2.47% | – |
| NVO | Exit | Novo-Nordisk A Sadr | $0 | – | -273,873 | -100.0% | -2.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Natera, Inc. | 23 | Q3 2023 | 20.5% |
| Ascendis Pharma A/S | 23 | Q3 2023 | 27.9% |
| NuCana plc | 23 | Q3 2023 | 15.2% |
| Synlogic Inc. (fmrly Mirna) | 22 | Q2 2023 | 0.9% |
| Y-mAbs Therapeutics, Inc. | 21 | Q3 2023 | 6.5% |
| ObsEva SA | 20 | Q4 2022 | 11.0% |
| Nucana PLC | 19 | Q3 2023 | 9.7% |
| SYNDAX PHARMACEUTICALS INC | 19 | Q3 2023 | 2.2% |
| PDS Biotechnology Corporation | 19 | Q3 2023 | 0.1% |
| Karuna Therapeutics, Inc. | 18 | Q3 2023 | 27.1% |
View Sofinnova Investments, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| OTONOMY, INC.Sold out | February 14, 2022 | 0 | 0.0% |
View Sofinnova Investments, Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Sofinnova Investments, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.